Gastrointestinal - Level 2.3 Flashcards

1
Q

Definition of cirrhosis?

A

o Cirrhosis develops progressively as a result of damage to the liver
o Normal smooth liver surface becomes distorted, nodular and fibrosed
 Distortion of hepatic vasculature, increased intrahepatic resistence and portal hypertension
 Damaged hepatocytes cause less synthesis of clotting factors and metabolic detoxification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Types of cirrhosis?

A

o Compensated – liver still functions effectively and no/few symptoms

o Decompensated – liver damaged where it cannot function adequately and clinical complications present (jaundice, ascites, variceal haemorrhage, hepatic encephalopathy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Epidemiology of cirrhosis?

A
  • More common in urban areas, social deprivation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Common risk factors of cirrhosis?

A

 Alcohol misuse
 Hepatitis B/C
 Obesity (>30)
 T2DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Less common risk factors of cirrhosis?

A

 Autoimmune liver disease (AH, PBC, PSC)
 Genetic (haemochromatosis, Wilson’s disease, alpha-1-antitrypsin deficiency, CF)
 Methotrexate use
 Budd-Chiari syndrome
 Sarcoidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Events causing decompensation in cirrhosis?

A

o Infection, portal vein thrombosis, surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Symptoms of cirrhosis?q

A
o	Asymptomatic
o	Malaise, fatigue, anorexia
o	Nausea
o	Weight loss
o	Muscle wasting
o	Abdominal pain
o	Oedema
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Signs of cirrhosis?

A
o	Jaundice
o	Leuconychia
o	Palmar erythema
o	Dupuytren’s contracture
o	Scratch marks
o	Abnormal bruising
o	Keiser Fleischer rings
o	Hair loss
o	Gynaecomastia
o	Spider naevi
o	Caput Medusae
o	Hepatosplenomegaly
o	Peripheral oedema
o	Ascites
o	Sepsis
o	Variceal bleeding
o	Encephalopathy (asterixis – sudden involuntary flexion-extension movements of wrist and MCP joints when arms are extended and eyes closed)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

When to suspect cirrhosis?

A

o Clinical findings consistent

o Chronic liver disease with low platelets, raised AST:ALT ratio, high bilirubin, low albumin or increased INR/PT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Diagnosing cirrhosis in primary care - when to perform transient elastography?

A

Transient elastography if:
 Patient with Hep C infection
 Men drinking >50 units per week for months
 Women drinking >35 units per week for months
 People diagnosed with alcohol-related liver disease

If not available, refer to hepatologist – liver biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Diagnosing cirrhosis in primary care - people with NAFLD?

A

o If NAFLD and advanced liver fibrosis (diagnosed with >10.51 on enhanced liver fibrosis test (ELF)):
 Transient elastography or acoustic radiation force

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When to refer suspected cirrhosis to hepatologist/GI?

A
	Hepatitis B
	PBC
	PSC
	Haemachromatosis
	Wilson’s disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Retesting in cirrhosis - if not diagnosed on initial testing?

A

If not diagnosed on initial testing – retest every 2 years in:
 Alcohol-related liver disease, Hep C, NAFLD or advance liver fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Tests to find cause in cirrhosis?

A
o	Ferritin, iron/total iron binding capacity
o	Hepatitis serology
o	Autoantibodies (ANA, AMA, SMA)
o	AFP
o	Alpha-1 anti-trypsin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Grading of cirrhosis?

A

o Child-Pugh grading and risk of variceal bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Management of cirrhosis - referral to secondary care?

A

 Diagnosed on transient elastography
 Decompensated liver disease
 Misuse alcohol
 End-stage liver disease requiring symptom or palliative care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Management of cirrhosis - primary care - general advice?

A
  • Diet
  • Alcohol abstinence
  • Smoking cessation
  • Driving – notify DVLA, cannot drive if hepatic cirrhosis with chronic encephalopathy
  • Seek medical advice before taking OTC drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Management of cirrhosis - primary care - symptom management?

A

• Pruritus – colestyramine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Management of cirrhosis - primary care - follow up?

A
  • Review medications and change dose as required

* Ensure specialist follow up

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Management of cirrhosis - specialist care - management?

A

Upper GI endoscopy – detect varices

Liver transplant - Advanced cirrhosis due to:
 Alcohol liver disease, hepatitis B&C, PBC, PSC, Wilson’s disease, alpha-1 antitrypsin deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Contraindications to liver transplant in cirrhosis?

A

o Extrahepatic malignancy, severe cardiopulmonary disease, sepsis, HIV, non-compliance with drug therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Monitoring cirrhosis in secondary care?

A

 Calculate Model for end-stage liver disease (MELD) score every 6 months for compensated cirrhosis – 12 or more high risk
 US + AFP every 6 months for HCC
 Upper GI endoscopy every 3 year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Managing complications of cirrhosis?

A

 1o prevention of bleeding - Endoscopic variceal band ligation
 If upper GI bleeding – prophylactic antibiotics
 Refractory Ascites - Transjugular intrahepatic portosystemic shunt
 Cirrhosis with ascites with protein level <15 until resolved - Prophylactic oral ciprofloxacin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Prognosis of cirrhosis?

A

o Irreversible – usually progresses over number of years

o Prognosis depends on cause, lifestyle, complications and hospital admissions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Complications of cirrhosis?
``` o Portal hypertension o Ascites o Hepatic Encephalopathy o Oesophageal varices (haemorrhage) o Infection o Hepatorenal syndrome o HCC o Portal vein thrombosis o Portal hypertensive gastropathy o Anaemia, coagulopathy ```
26
Description of hepatic encephalopathy?
 Dysfunction of brain due to liver insufficiency and related to nitrogenous waste products (ammonia and glutamine) in brain  Present with cognitive and behavioural changes, sleep disturbance, motor problems and altered consciousness  Predisposed by constipation, dehydration, infection, GI bleed, drugs (opiates, benzodiazepines, diuretics)
27
What is hepatorenal syndrome?
 Changes to circulation due to cirrhosis with water and sodium retention and renal vasoconstriction  Decrease renal blood flow and reduced glomerular filtration rate
28
Definition of autoimmune hepatitis?
- Chronic disease with continuing hepatocellular inflammation and necrosis which progresses to cirrhosis - HLA implicated
29
Types of autoimmune hepatitis?
o 1 – presence of ASMA or ANA | o 2 – presence of anti-LKM-1 or anti-liver cytosolic 1 antibodies
30
Epidemiology of autoimmune hepatitis?
- Young/Middle Aged women but can occur in anybody
31
Associated conditions of autoimmune hepatitis?
- Associated disease: pernicious anaemia, UC, thyroiditis, T1DM, PSC, RA, glomerulonephritis
32
Symptoms of autoimmune hepatitis?
o Often insidious onset o Fatigue, myalgia, pruritus, nausea o Upper abdominal pain, anorexia, diarrhoea
33
Signs of autoimmune hepatitis?
Same as cirrhosis
34
Investigations of autoimmune hepatitis?
Bloods o FBC - Normochromic anaemia o LFTs - Raised ALT and AST o Hypergammaglobulinaemia Autoantibodies o ANA, ASMA, ALKM1, ALC1
35
Diagnostic investigation of autoimmune hepatitis?
Liver biopsy - diagnostic o Chronic hepatitis o Mononuclear infiltrates
36
Management of autoimmune hepatitis?
Immunosuppression o Prednisolone 30mg for 1 month and then decrease by 5mg each month to maintenance dose o Azathioprine Liver transplant o If decompensated cirrhosis or failure to respond to medication, recurrence may occur
37
Definition of primary sclerosing cholangitis?
- Progressive cholestasis with bile duct inflammation and structures
38
Associated diseases of primary sclerosing cholangitis?
- Associated with males, HLA, AIH, IBD
39
Symptoms of primary sclerosing cholangitis?
o Asymptomatic o Jaundice o Pruritus o If advanced – ascending cholangitis, cirrhosis and hepatic failure
40
Investigations of primary sclerosing cholangitis?
Bloods o LFT – elevated ALP, GGT, bilirubin o Abnormal albumin or PT if disease progressed o Raised ANCA, aCL, ANA US o Bile duct dilatation and liver changes MRCP to visualise the duct Liver biopsy - staging
41
Management of primary sclerosing cholangitis - surveillance?
- Risk of bile duct, gall bladder, liver and colon cancer so: o Yearly colonoscopy + US
42
Management of primary sclerosing cholangitis - Symptomatic control?
- Pruritus – colestyramine - Nutrition – Fat-soluable vitamins – ADEK - Prevent progression – ursodeoxycholic acid, avoid alcohol - Stricture – ERCP balloon dilatation
43
Management of primary sclerosing cholangitis - end-stage liver disease?
- Liver transplant for end-stage liver disease
44
Definition of primary biliary cirrhosis?
- Progressive autoimmune disease of biliary system - Destruction of interlobular bile ducts (canals of Hering) causing intrahepatic cholestasis which damages cells, leading to scarring, fibrosis and cirrhosis - Women 10x
45
Causes of primary biliary cirrhosis?
- Causes by anti-mitochondrial antibody (AMA)
46
Symptoms of primary biliary cirrhosis?
- Asymptomatic - Fatigue - Pruritus - RUQ pain - Later stages – dark urine, pale stools
47
Investigations of primary biliary cirrhosis - bloods?
``` Bloods o FBC (ESR raised) o LFTs  ALP raised o Late stage – raised bilirubin, PT and albumin ``` Antibodies (AMA present)
48
Investigations of primary biliary cirrhosis - imaging?
- US of liver
49
Investigations of primary biliary cirrhosis - diagnosis?
Liver biopsy | o AMA with cholestatic liver biochemistry
50
Stages of primary biliary cirrhosis?
o Portal stage – portal inflammation and bile duct abnormalities o Periportal stage – periportal fibrosis o Septal – septal fibrosis and inflammation o Cirrhotic – nodules with inflammation
51
Management of primary biliary cirrhosis - symptomatic?
``` o Pruritus – colestyramine o Diarrhoea – codeine phosphate o Fat-soluble vitamin ADEK o Ursodeoxycholic acid o Liver transplant for end-stage or intractable pruritus ```
52
Monitoring of primary biliary cirrhosis?
o Regular LFTs, AFP and liver US
53
Definition of hereditary haemochromatosis?
- Autosomal recessive deficiency of iron regulating hormone hepcidin - Causes increased intestinal absorption of iron leading to accumulation in tissues, especially the liver, and organ damage (joints, liver, heart, pancreas, pituitary, adrenals, skin)
54
Causes of hereditary haemochromatosis?
- Caused by mutation on HFE gene on chromosome 6 | - Penetrance varies
55
Symptoms & signs of hereditary haemochromatosis?
- Symptoms start in 40-60 in men and post-menopausal women - Fatigue - Weakness, arthralgia - Erectile dysfunction, decreased libido - Amenorrhoea, hypogonadism - Diabetes mellitus - Arrhythmias, dilated cardiomyopathy - Cirrhosis - Impaired memory, mood swings and depression - Slate-grey skin
56
Investigations if Northern European and features of hereditary haemochromatosis?
- If Northern European and features of HH: | o FBC, LFTs, ferritin, transferrin saturation
57
Investigations if raised ferritin and transferrin with normal FBC in hereditary haemochromatosis?
- If raised ferritin and transferrin (>300 and 50% males, >200 and 40% females) with normal FBC: o Genetic testing
58
Further investigations of hereditary haemochromatosis?
- MRI to defect and quantify hepatic iron excess | - Biopsy not usually needed – by if so, Perl’s stain for iron
59
Investigations to family members in case of hereditary haemochromatosis?
- Offer lab testing to family members – FBC, LFTs, ferritin, transferrin and genetic testing
60
Management of hereditary haemochromatosis - when to refer?
- If serum ferritin >1000mcg/L and raised transaminases: | o Refer to hepatologist for fibrosis assessment
61
Management of hereditary haemochromatosis - specialist management
``` - Venesection - weekly o 400-500ml blood o Aim for SF 20-30 and Tsat <50% o Monitor FBC and SF/Tsat o Maintenance every 2-3 months ``` - Desferrioxamine if intolerant to venesection Liver Transplant
62
Management of hereditary haemochromatosis - monitoring?
o AFP and US every 6 months
63
Complications of hereditary haemochromatosis ?
- Liver fibrosis - Cirrhosis - HCC
64
Definition of Wilson's Disease?
- Inherited disorder of biliary copper excretion with excess copper in liver and CNS o ATPase mutation prevents movement of copper across intracellular membranes and supports excretion of copper in bile
65
Causes of Wilson's Disease?
- Caused by autosomal recessive mutation in ATP7B, on chromosome 13 - Onset during 20-30s
66
Symptoms of Wilson's Disease?
- Young people with liver disease (hepatitis, cirrhosis, fulminant liver failure)
67
Signs of Wilson's Disease - neurological?
``` o Tremor o Dysarthria o Dysphagia o Dyskinesia o Dystonia o Dementia o Parkinsonism o Ataxia ```
68
Signs of Wilson's Disease - mood?
o Depression, mania, labile emotions, decreased/increased libido, personality change
69
Signs of Wilson's Disease - cognition?
o Memory impairment, slow to solve problems, low IQ, delusions
70
Signs of Wilson's Disease -other?
- Kayser-Fleischer ring in iris - Blue nails, arthritis, grey skin - Cardiomyopathy, pancreatitis, infertility
71
Investigations of Wilson's Disease?
- Urine – 24h copper excretion is high (>100mcg/24h) - Bloods (LFTs raised) - Serum copper – typically <11 - Serum caeruloplasmin - <200mg/L (<140 is pathognomonic) o Falsely low – nephrotic, protein deficient, chronic liver disease o Falsely high – inflammation, infection, pregnancy
72
Diagnostic investigations of Wilson's Disease?
- Slit Lamp – Kayser-Fleischer rings in iris - Liver biopsy – increased hepatic copper - MRI
73
Management of Wilson's Disease - if family member diagnosed?
o Genetic testing of ATP7B gene
74
Management of Wilson's Disease - general advice?
 Avoid alcohol |  Avoid eating food with high copper (liver, chocolate, nuts, mushrooms, legumes, shellfish)
75
Management of Wilson's Disease - drugs?
 Lifelong penicillamine (500mg every 8 hours for 1y then maintenance of 0.75-1g/d) • Chelating agent – excretes copper in urine  Zinc  Trientine dihydrochloride o Liver transplant if severe liver disease
76
Management of Wilson's Disease - monitoring?
U&E, FBC, clotting | Annual slit lamp study
77
Management of Wilson's Disease - follow up?
 Lifelong follow-up
78
Definition of Budd-Chiari syndrome?
- Hepatic vein obstruction causes congestive ischaemia and hepatocytes damage
79
Causes of Budd-Chiari syndrome?
o Haematological – PCV, thrombophilia, antiphospholipid syndrome, PNH o Blood flow – RHF, contractive pericarditis, right atrial myxoma o Obstetric – during or postpartum o Drugs – COCP, HRT o Infection – amoebic abscess, aspillergosis, syphilis, TB o Inflammations – IBD, sarcoid, SLE, Sjogrens o Malignancy – HCC, RCC, Wilm’s tumour, adrenal carcinoma o Trauma or surgery
80
Symptoms and signs of Budd-Chiari syndrome?
- RUQ pain - Ascites - Hepatomegaly - Jaundice - AKI - Dilated abdominal wall veins
81
Investigations of Budd-Chiari syndrome?
- LFTs raised - Ascitic tap – high in protein - Doppler USS - MRI/CT
82
Management of Budd-Chiari syndrome?
- Treat ascites - Surgical o Angioplasty o Transjugular intrahepatic porto-systemic shunt o Surgical shunt - Anticoagulation lifelong - Liver transplant if fulminant hepatic necrosis or cirrhosis
83
Physiology of alpha-1-antitrypsin?
o Glycoprotein produced in liver, serine protease inhibitor | o Function – balance action of neutrophil-protease enzymes in lungs (neutrophil elastase)
84
Pathology of alpha-1-antitrypsin deficiency?
o Autosomal recessive deficiency means protein cannot pass out of liver and accumulates, leading to hepatocyte damage o Deficiency leads to elastase breakdown of lungs alveolar walls and emphysema
85
Mutation of alpha-1-antitrypsin deficiency?
- Mutation on SERPINA1 gene on chromosome 14 – common amongst white people
86
Symptoms in lung of alpha-1-antitrypsin deficiency?
o Smokers develop earlier | o COPD symptoms – diffuse emphysema – SOB, wheeze, cough
87
Symptoms in liver of alpha-1-antitrypsin deficiency?
o Hepatitis o Cirrhosis o Liver failure
88
Investigations of alpha-1-antitrypsin deficiency?
- LFTs abnormal - Serum alpha1-antitrypsin levels low - Liver biopsy o Periodic acid Schiff (PAS) positive o Diastase resistant globules - Phenotype - CXR, spirometry and CT for lung involvement
89
Management of alpha-1-antitrypsin deficiency -general measures??
- Family members investigated | - Stop smoking
90
Management of alpha-1-antitrypsin deficiency - lung disease?
o COPD managed as COPD o Lung transplant o Pneumococcal and yearly influenza vaccines
91
Management of alpha-1-antitrypsin deficiency - liver disease?
o LFTs monitored o Treat cirrhosis o 6-monthly AFP and US – HCC o Liver transplant
92
Definition of primary NAFLD?
Excess fat accumulation in liver (steatosis), where hepatocytes contain >5% of triglycerides which is not due to alcohol or secondary causes o Spectrum of liver disease – associated with insulin resistance o Ranges from hepatic steatosis, through to non-alcoholic steatohepatitis (NASH) which may progress to liver fibrosis and cirrhosis o NASH is liver expression of metabolic syndrome
93
Definition of secondary NAFLD?
caused by drugs, Hep C and endocrine conditions
94
Epidemiology of NAFLD?
- NAFLD commonest cause of abnormal LFT - Commonest cause of liver disease in western countries - Prevalence highest in males aged 40-60 - Doubled in last 20 years
95
Cause of NAFLD?
o Thought to be due to insulin resistance, obesity and metabolic syndrome o Also, oxidative stress and blood flow compromise
96
Risk factors of NAFLD?
``` o Metabolic – central obesity, T2DM, hypertension, hyperlipidaemia o Obstructive sleep apnoea o Polycystic ovary disease o Hypothyroidism o FHx of NAFLD o Hispanic or Asian people o Drugs – NSAIDs, amiodarone, corticosteroids, diltiazem, methotrexate and tamoxifen o Hepatits C, Wilsons disease ```
97
Symptoms of NAFLD?
- Asymptomatic - Mild fatigue, malaise - RUQ abdominal discomfort
98
When to suspect NAFLD?
o Risk factors (T2DM, metabolic syndrome) o Persistent elevation of LFT for >3 months – typically ALT 3x upper limit of normal and >AST o Upper abdominal US – fatty changes (increased echogenicity) • LFTs and US may be normal in NAFLD
99
Assessment of alcohol in NAFLD?
- Alcohol intake: <2.5 units per day for women and <3.75 units per day for men a cut-off o If above this value then alcoholic fatty liver disease
100
Bloods to test in NAFLD - if indicated?
``` o LFT o FBC o Clotting o Hep B&C serology o Auto-antibodies o Ferritin o Serum caeruloplasmin o Alpha-1-antitrypsin deficiency o HbA1c o Lipids o U&E o TFTs o IgA TTG ```
101
Assessing risk of NAFLD?
Enhanced liver fibrosis test (ELF)  If >10.51 then advanced  Algorithm measuring hyaluronic acid, amino-terminal propeptide of type 3 procollagen (PIIINP) and tissue inhibitor of metalloproteinase 1 (TIMP-1) NAFLD Fibrosis Score (intermediate or high score suggests fibrosis) Fibrosis (FIB)-4 Score
102
When to diagnose advanced liver disease and refer to hepatology in NAFLD?
o NAFLD and ELF >10.51
103
How to investigate children <18 years old for NAFLD?
o Offer US if have T2DM or metabolic syndrome and do not misuse alcohol o Refer all children suspected o Diagnosed if US shows fatty liver and other causes ruled out o Retest every 3 years if T2DM or metabolic syndrome and normal US
104
Management of NAFLD - general advice?
o Regular physical exercise o Healthy diet o Weight loss – 10% in 6 months o Do not exceed weekly alcohol limits
105
Management of NAFLD - statins?
o Keep taking generally | o Stop statins if liver enzyme doubles within 3 months of starting statins
106
Management of NAFLD - follow up in primary care?
o Annual – U&E, HbA1c, Lipids | o 3-yearly – assess risk of liver fibrosis – ELF test
107
Management of NAFLD - referral to hepatology?
o High risk of advanced liver fibrosis – ELF>10.51 o Signs of advanced liver fibrosis o Uncertainty
108
Management of NAFLD - secondary care investigations?
o Transient elastography (Fibroscan) | o Liver biopsy
109
Management of NAFLD - secondary care - surveillance?
 US and AFP every 6 months
110
Management of NAFLD - secondary care - drug treatments?
o Drug treatments – pioglitazone or vitamin E |  Re-test ELF after 2 years to see if effective – if risen then stop drug and switch
111
Management of NAFLD - secondary care - definitive treatment?
o Liver transplant
112
Prognosis of NAFLD?
o Depends on stage of disease and co-morbidities  Overweight, obese and T2DM at more risk or progression o If simple steatosis – cirrhosis develops in only 0-4% of people over 10-20 years o NASH has increased risk of HCC, cirrhosis and fibrosis
113
Complications of NAFLD?
``` o Morbidity from CVD and liver disease  Liver • Portal hypertension • Variceal haemorrhage • Liver failure • HCC • Sepsis  Metabolic • Hypertension, CKD, T2DM  CVD • AF, MI, CVA ```
114
Definition of ascites?
- Fluid within peritoneal cavity
115
Pathology of ascites?
o Portal hypertension o Secondary to salt and water retention o Low Albumin
116
Definition and grading of uncomplicated ascites?
Not infected and not associated with hepatorenal syndrome Graded:  1 (mild) – only detectable by USS  2 (moderate) – moderate symmetrical distention of abdomen  3 (severe) – marked abdominal distention
117
Definition and groups of refractory ascites?
Ascites that cannot be mobilised or early recurrence of which cannot be satisfactorily prevented by medical therapy Groups:  Diuretic-resistant – refectory to diuretics and salt restriction  Diuretic-intractable – development of diuretic complications that preclude use
118
Causes of ascites - transudate?
```  Cirrhosis  Hepatic Outflow obstruction  Budd Chiari syndrome  Heart Failure  Constrictive pericarditis  Malignancy  Meig’s syndrome ```
119
Causes of ascites - exudate?
 Peritoneal carcinomatosis/TB  Pancreatitis  Nephrotic syndrome  Lymph obstruction
120
Symptoms and signs of ascites?
- Discomfort - Nausea and appetite suppression - Fullness in flanks - Fluid may push out umbilical hernias - Shifting dullness, fluid thrill - May be pleural effusion and peripheral oedema
121
Bloods to perform in ascites?
``` o FBC o U&E o LFTs o Clotting (Prothrombin time) o TFTs ```
122
Imaging to perform in ascites?
Abdominal USS
123
Diagnostic test in ascites?
- Diagnostic Paracentesis of 10-20ml of ascitic fluid o Albumin (>11g/L in transudate, <11g/L in exudate) o Neutrophil count (>250 SPB) o Culture o Amylase if suggestion of pancreatitis o Cytology if suggestion of malignancy
124
Management of ascites - salt?
- Salt Restriction o No-added salt diet, 5.2g salt/day - If sodium <120mmol/L stop diuretics, caution when <135mmol/L
125
Management of ascites - drug therapy?
o Spironolactone from 100mg/day to 400mg/day  Add furosemide from 40mg/day up to 160mg/day if fails to resolve  Aim for weight loss <0.5kg/day
126
Management of ascites - further management?
- Therapeutic paracentesis (first line in large or refractory ascites) o If <5 litres – plasma expander given o If >5 litres – volume expander given using 8g albumin/litre of ascites removed - Transjugular Intraheptic Portosystemic Shunt o Used for treatment refractory ascites requiring frequent therapeutic paracentesis - Liver transplant in cirrhotic ascites
127
Complications of ascites?
o Hyponatraemia o Spontaneous Bacterial Peritonitis o Hepatorenal syndrome
128
Definition of spontaneous bacterial peritonitis?
 Ascitic neutrophil count of >250cells/mm3 |  Commonly E.coli & Kleisiella
129
Symptoms of spontaneous bacterial peritonitis?
 Symptoms – tender abdomen, fever, vomiting, deterioration, asymptomatic
130
Treatment of spontaneous bacterial peritonitis?
* Empirical Abx – Cefotaxime * Prophylactic Abx – Norflaxacin 400mg/day * Consider for liver transplant * Albumin if renal impairment developing
131
Prognosis of ascites?
o 50% mortality over 2 years | o Ascites signifies need to consider liver transplant
132
Definition of ulcerative colitis?
- Along with Crohn’s disease known as inflammatory bowel disease - Chronic, relapsing-remitting, non-infectious inflammatory disease of GI tract - Mucosa of rectum and colon affected - Probable autoimmune condition triggered by environmental factors causing inflammation
133
Pathology of ulcerative colitis - macroscopic?
 Begins in rectum and extends proximally  Continuous  Red mucosa, ulcers and pseudopolyps  Backwash ileitis
134
Pathology of ulcerative colitis - microscopic?
 Mucosal inflammation  No granulomas  Goblet cell depletion  Crypt abscesses
135
Epidemiology of ulcerative colitis?
- Most common form of IBD - Around 1 in 1000 prevalence - Peak between 15-25 and 55-65 years
136
Risk factors of ulcerative colitis?
o Family History o OCP o NOT smoking o Stress
137
Symptoms of ulcerative colitis?
``` o Episodic or chronic diarrhoea +/- blood/mucous o Crampy abdominal discomfort o Increased bowel frequency o Urgency/Tenesmus = Rectal UC o Fever/Malaise/Weight loss ```
138
Signs of ulcerative colitis?
``` o In acute UC – fever, tachycardia, tenderness o Clubbing o Aphthous Ulcers o Erythema Nodosum o Pyoderma gangrenosum o Conjunctivitis/Episcleritis/Iritis o Arthritis ```
139
Bloods if ulcerative colitis suspected?
Bloods  FBC (anaemia, low B12), ferritin, ESR, CRP, U&E, LFTs (raised platelets, abnormal LFTs), blood culture (if needed), TTG, Faecal calprotectin (sign of inflammation)
140
Cultures if ulcerative colitis suspected?
o Stool Culture |  M, C & S for C. diff, campylobacter, E.coli
141
Imaging to perform in ulcerative colitis?
o Colonoscopy  Allows biopsy and confirmation o Barium Enema  Detects ileal disease o AXR, Erect CXR – acute colitis
142
Severity assessment of ulcerative colitis?
Truelove and Witts Criteria Based on bloody stools per day, pulse, temperature, Hb, ESR, CRP
143
Management of ulcerative colitis - referral?
- Urgent referral to gastroenterology
144
Management of ulcerative colitis - specialist investigations?
o Colonoscopy and biopsy – inflammation extending from rectum proximally, erythema, granulomas, ulceration, crypt abscesses o CT scan to stage UC
145
Management of ulcerative colitis - surveillance?
Offer when symptoms started 10 years ago and have UC or Crohn’s colitis Baseline colonoscopy with chromoscopy and targeted biopsy of any abnormal areas to determine risk  Low risk – colonoscopy at 5 years  Intermediate risk - colonoscopy at 3 years  High risk – colonoscopy at 1 year
146
Management of ulcerative colitis - symptoms management?
o Diarrhoea – bulk-forming laxative (ispaghula husk) o Fistula – long term antibiotics (metronidazole or ciprofloxacin), surgery o Abdominal pain – paracetamol 1st line, avoid NSAIDs when possible, chronic pain service
147
Management of ulcerative colitis - medical - inducing remission - mild-to-moderate proctitis/proctosigmoiditis/extensive UC?
5-ASA (sulfasalazine, mesalazine, olsalazine) OD topical dose If no remission in 4 weeks – oral aminosalicylate If further treatment needed - Oral or PR prednisolone for 2 weeks and decrease
148
Management of ulcerative colitis - medical - inducing remission - moderate to severe UC?
5-ASA (sulfasalazine, mesalazine, olsalazine) OD topical dose If no remission in 4 weeks – oral aminosalicylate If further treatment needed - Oral or PR prednisolone for 2 weeks and decrease Tofacitinib
149
Management of ulcerative colitis - inducing remission - acute severe UC?
* MDT Management * Assess likelihood of needing surgery (stool frequency >8/day, pyrexia, tachycardia, colonic dilation, low albumin, low Hb, high platelet, >CRP) * NBM and IV fluids * Prophylactic heparin • Hydrocortisone IV o IV Ciclosporin if cannot take IV steroids or not improvement within 72 hours o Infliximab if ciclosporin contraindicated • Surgery o Indicated in perforation, haemorrhage, toxic dilatation, failed medical therapy o Sub-total colectomy with rectal preservation o Total proctocolectomy with ileostomy curative • Daily bloods and X-rays
150
Management of ulcerative colitis - maintaining remission - proctitis or proctosigmoiditis?
• Topical ASA alone +/- oral ASA
151
Management of ulcerative colitis - maintaining remission - left sided and extensive UC?
• Low dose oral ASA
152
Management of ulcerative colitis - maintaining remission - other options?
• Oral azathioprine or mercaptopurine | o If 2 or more inflammatory exacerbations in 12 months needing systemic corticosteroids
153
Management of ulcerative colitis - monitoring?
o Bloods – Vitamin B12, folate, calcium and vitamin D
154
Prognosis of UC?
o Lifelong relapses and remissions | o May need colectomy, 1 in 10 after 10 years
155
Complications of UC?
``` o Bleeding o Toxic Megacolon o Colorectal cancer o VTE o Osteoporosis ```
156
Definition of Crohn's disease?
- Chronic inflammatory, relapsing and remitting inflammatory disease of GI tract - Known with UC collectively as inflammatory bowel disease - Inflammation involves discrete parts of the GI tract, anywhere from mouth to anus (called skip lesions) - Full thickness of intestinal wall is inflamed
157
Pathology of Crohn's disease - macroscopic?
 Affects all GI  Oral and perianal disease  Skip lesions  Deep ulcers and fissure in mucosa – cobblestone
158
Pathology of Crohn's disease - microscopic?
 Transmural inflammation |  Non-caseating granulomas with Langerhans– 50%
159
Epidemiology of Crohn's disease?
- Mostly in terminal ileum - 1 in 10000 incidences - Peak 20-40 years
160
Aetiology of Crohn's disease?
Cause unknown
161
Risk factors of Crohn's disease?
``` o Familial o Genetic  NOD2 and CARD15 genes confer risk o Smoking o Stress o Gastroenteritis o NSAIDs ```
162
Symptoms of Crohn's disease?
``` o Diarrhoea o Urgency o Abdominal Pain o Weight Loss o Fever/Malaise/Anorexia o Nausea and Vomiting ```
163
Signs of Crohn's disease?
``` o Clubbing o Aphthous ulcers o Perianal abscesses/fistula/stricture o Erythema nodosum o Pyoderma gangrenosum o Conjunctivitis/Episcleritis/Iritis o Arthritis o Ankylosing Spondylitis ```
164
Investigations of Crohn's disease?
- Bloods o FBC (anaemia), CRP, ESR, U&E, LFTs (low albumin), ferritin, B12, coeliac screen, o Faecal calprotectin (differentiate between IBD and IBS) - Stool Sample o M, C & S – for C. diff, Campylobacter, E. coli - Colonoscopy and biopsy - Barium Enema
165
Management of Crohn's disease - referral?
- If Crohn’s disease suspected, urgent referral to gastroenterologist for confirmation of diagnosis and treatment
166
Management of Crohn's disease - specialist investigations?
o Colonoscopy with histology – discontinuous colonic inflammation or ulceration, cobblestone appearance and rectal sparing o CT used to stage Crohn’s disease
167
Management of Crohn's disease - education?
o Stop smoking
168
Management of Crohn's disease - symptom management?
o Diarrhoea – loperamide, bulk-forming laxative (ispaghula husk) o Fistula – long term antibiotics (metronidazole or ciprofloxacin), surgery o Abdominal pain – paracetamol 1st line, avoid NSAIDs when possible, chronic pain service
169
Management of Crohn's disease - inducing remision - stepwise approach?
 Prednisolone/methylprednisolone/IV hydrocortisone – 12 months • Consider aminosalicylate if prednisolone CI  Add azathioprine or mercaptopurine • If 2 or more inflammatory exacerbations in 12 month period or steroids not tolerated  Add methotrexate • If 2 or more inflammatory exacerbations in 12 month period or steroids not tolerated  Add Infliximab or adalimumab
170
Management of Crohn's disease - maintaining remission?
* Azathioprine or mercaptopurine * Methotrexate * Sulfasalazine * Infliximab * DO NOT GIVE STEROIDS
171
Managing complications of Crohn's disease?
 Strictures – balloon dilation |  Fistula – plug insertion or ablation
172
Management of Crohn's disease - acute attack = mild?
• Prednisolone PO for 5 weeks
173
Management of Crohn's disease - acute attack - severe?
* Admit * NBM, IV fluids * IV & PR hydrocortisone * Metronidazole * Daily bloods and imaging * If not improving, consider infliximab and adalimumab
174
Management of Crohn's disease - surgery?
o 50% need >1 operation | o Aims to rest distal disease (pouch), resection (short-bowel syndrome)
175
Monitoring of Crohn's disease?
o Bloods – Vitamin B12, folate, calcium and vitamin | d
176
Prognosis of Crohn's disease?
o Around 50% people need surgery o Slightly higher mortality o Poor prognosis with early, severe disease
177
Complications of Crohn's disease?
``` o Psychological impact o Toxic dilatation o Haemorrhage o Abscesses, strictures, fistulas o Anaemia, malnutrition o Colorectal and small bowel cancer o Osteopenia ```